Brief: Decibel Therapeutics Reports Q1 Financial Results
May 12 (Reuters) - Decibel Therapeutics Inc DBTX.O :
* DECIBEL THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND CORPORATE UPDATE
* DECIBEL - BELIEVES ITS EXISTING CASH, CASH EQUIVALENTS &
AVAILABLE-FOR-SALE SECURITIES WILL FUND ITS PIPELINE PROGRAMS &
OPERATING EXPENSES INTO 2024
Source text for Eikon: ID:nGNX7RSj5T
Further company coverage: DBTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Decibel Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Domo, BlackBerry, Rite Aid
U.S. STOCKS ON THE MOVE-Decibel Therapeutics, Affirm Holdings, Medtronic
Decibel rises on FDA's 'fast-track' tag for hearing-loss therapy
Brief: Decibel Therapeutics Says US Food And Drug Administration Had Granted Fast Track Designation For DB-OTO
Decibel Therapeutics Inc reports results for the quarter ended in June - Earnings Summary